The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells.

These previously unknown observations suggest that the hypoxic TME may promote malignant progression and therapy resistance by coordinating induction, selection and/or preferential maintenance of the CSC-like phenotype in tumor cells.